1520 related articles for article (PubMed ID: 31412603)
1. Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome.
Khan I; Ullah N; Zha L; Bai Y; Khan A; Zhao T; Che T; Zhang C
Pathogens; 2019 Aug; 8(3):. PubMed ID: 31412603
[TBL] [Abstract][Full Text] [Related]
2. Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?
Nishida A; Nishino K; Sakai K; Owaki Y; Noda Y; Imaeda H
World J Gastroenterol; 2021 Jun; 27(23):3317-3326. PubMed ID: 34163114
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory Bowel Diseases: The Role of Gut Microbiota.
De Musis C; Granata L; Dallio M; Miranda A; Gravina AG; Romano M
Curr Pharm Des; 2020; 26(25):2951-2961. PubMed ID: 32310042
[TBL] [Abstract][Full Text] [Related]
4. Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.
Nagao-Kitamoto H; Shreiner AB; Gillilland MG; Kitamoto S; Ishii C; Hirayama A; Kuffa P; El-Zaatari M; Grasberger H; Seekatz AM; Higgins PD; Young VB; Fukuda S; Kao JY; Kamada N
Cell Mol Gastroenterol Hepatol; 2016 Jul; 2(4):468-481. PubMed ID: 27795980
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota in the pathogenesis of inflammatory bowel disease.
Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
[TBL] [Abstract][Full Text] [Related]
6. Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet?
Serban DE
Nutr Clin Pract; 2015 Dec; 30(6):760-79. PubMed ID: 26452390
[TBL] [Abstract][Full Text] [Related]
7. Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives.
Roy S; Dhaneshwar S
World J Gastroenterol; 2023 Apr; 29(14):2078-2100. PubMed ID: 37122604
[TBL] [Abstract][Full Text] [Related]
8. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
9. Antibiotics, probiotics and prebiotics in IBD.
Bernstein CN
Nestle Nutr Inst Workshop Ser; 2014; 79():83-100. PubMed ID: 25227297
[TBL] [Abstract][Full Text] [Related]
10. The Gut Microbiome as a Target for IBD Treatment: Are We There Yet?
Knox NC; Forbes JD; Van Domselaar G; Bernstein CN
Curr Treat Options Gastroenterol; 2019 Mar; 17(1):115-126. PubMed ID: 30661163
[TBL] [Abstract][Full Text] [Related]
11. Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients.
Matijašić M; Meštrović T; Perić M; Čipčić Paljetak H; Panek M; Vranešić Bender D; Ljubas Kelečić D; Krznarić Ž; Verbanac D
Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27104515
[TBL] [Abstract][Full Text] [Related]
12. Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches.
Alshehri D; Saadah O; Mosli M; Edris S; Alhindi R; Bahieldin A
Bosn J Basic Med Sci; 2021 Jun; 21(3):270-283. PubMed ID: 33052081
[TBL] [Abstract][Full Text] [Related]
13. Highlighting the Relevance of Gut Microbiota Manipulation in Inflammatory Bowel Disease.
Pavel FM; Vesa CM; Gheorghe G; Diaconu CC; Stoicescu M; Munteanu MA; Babes EE; Tit DM; Toma MM; Bungau S
Diagnostics (Basel); 2021 Jun; 11(6):. PubMed ID: 34203609
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.
Qiao YQ; Cai CW; Ran ZH
J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467
[TBL] [Abstract][Full Text] [Related]
15. Beneficial Effects of Probiotics, Prebiotics, Synbiotics, and Psychobiotics in Inflammatory Bowel Disease.
Wasilewski A; Zielińska M; Storr M; Fichna J
Inflamm Bowel Dis; 2015 Jul; 21(7):1674-82. PubMed ID: 25822014
[TBL] [Abstract][Full Text] [Related]
16. Faecal microbiota transplantation: looking beyond clostridium difficile infection at inflammatory bowel disease.
Patel K; Patel A; Hawes D; Shah J; Shah K
Gastroenterol Hepatol Bed Bench; 2018; 11(1):1-8. PubMed ID: 29564058
[TBL] [Abstract][Full Text] [Related]
17. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
[TBL] [Abstract][Full Text] [Related]
18. Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease.
Ghouri YA; Richards DM; Rahimi EF; Krill JT; Jelinek KA; DuPont AW
Clin Exp Gastroenterol; 2014; 7():473-87. PubMed ID: 25525379
[TBL] [Abstract][Full Text] [Related]
19. The role of the gut microbiota in the treatment of inflammatory bowel diseases.
Aggeletopoulou I; Konstantakis C; Assimakopoulos SF; Triantos C
Microb Pathog; 2019 Dec; 137():103774. PubMed ID: 31586663
[TBL] [Abstract][Full Text] [Related]
20. Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility.
Scaldaferri F; Gerardi V; Lopetuso LR; Del Zompo F; Mangiola F; Boškoski I; Bruno G; Petito V; Laterza L; Cammarota G; Gaetani E; Sgambato A; Gasbarrini A
Biomed Res Int; 2013; 2013():435268. PubMed ID: 23991417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
